News

Lower Rice Consumption May Be Tied to Crohn's


 

CHICAGO — The increasing prevalence of Crohn's disease in Japan correlates closely with decreased consumption of rice, Ryosuke Shoda, M.D., said at the annual Digestive Disease Week.

Crohn's disease was once almost unknown in Japan, Dr. Shoda said in a poster presentation that reviewed the epidemiology of Crohn's disease and trends in the consumption of fiber from rice and other sources in the Japanese diet. In the early 1960s and before, rice was the main source of dietary fiber in Japan, providing the average citizen with about 28 g of fiber per day. Today, the average intake of fiber from rice is 12–15 g/day.

Meanwhile, the prevalence of Crohn's disease went from virtually nothing in the 1960s to 2.9 per 100,000 persons in the mid-1980s and to about 14 per 100,000 today, said Dr. Shoda, chief of the department of general internal medicine at the International Medical Center of Japan, Tokyo.

Data on fiber consumption and Crohn's disease from the Japanese Ministry of Health, Welfare, and Labor from 1966 to 1993 show that the rising prevalence of Crohn's disease closely paralleled the decreasing intake of fiber and rice and the increasing intake of fiber from wheat and grains, Dr. Shoda said.

Of nine sources of fiber studied, rice was the only one that was independently correlated with the prevalence of Crohn's disease. The other sources were wheat and grain, potatoes, fruit, vegetables, beans, seaweed, sweets, and seeds. When changes in the consumption of animal fat were included in the analysis, rice remained the only independent factor.

Breakfast is the meal that has changed the most in Japan and is probably the most responsible for the decline in rice consumption, Dr. Shoda said in an interview.

Many people in Japan now eat bread rather than rice with breakfast.

Recommended Reading

Study Design May Miss Hypnotherapy's Benefits
MDedge Family Medicine
Agenda for Liver and Biliary Disease Research Set Until 2015
MDedge Family Medicine
Reflux Assessment May Guide GERD Treatment
MDedge Family Medicine
Evaluate History and Meds In Supraesophageal GERD
MDedge Family Medicine
Obesity, Not Diet, Seems to Boost Risk for GERD and Esophagitis
MDedge Family Medicine
Stem Cells Promising for Crohn's-Related Fistulas
MDedge Family Medicine
Fatty Liver Disease Common in U.S. Adolescents
MDedge Family Medicine
Data Watch: More Comorbidities Found in Obese Patients
MDedge Family Medicine
What is the best treatment for gastroesophageal reflux and vomiting in infants?
MDedge Family Medicine
Aspirin plus PPI safer than clopidogrel if there is history of GI bleeding
MDedge Family Medicine